Baupost Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Baupost Group’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-160,829	Closed	-$6.39M	–	52
2016 Q3	$6.39M	Buy	+160,829	New	+$1.79M	0.09%	40

Baupost Group's TBRA Position: Q4 2016 in Review

Baupost Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 160,829 shares — an estimated $6.39M sold.

Baupost Group first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $6.39M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Baupost Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Baupost Group sold 160,829 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $6.39M.
Baupost Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Baupost Group's Tobira Therapeutics, Inc. Common Stock position peaked at $6.39M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Baupost Group's 13F filing for Q4 2016, filed 14 Feb 2017.